The dog days of summer are here and IPO activity has slowed, but that hasn’t stopped some biotech companies from securing a place in the line leading to Wall Street. Late Friday, SpringWorks Therapeutics and Satsuma Pharmaceuticals filed paperwork to go... Read more »
An anti-inflammatory drug that AbbVie has been developing as a successor to adalimumab (Humira), the world’s top-selling drug, won the regulatory OK Friday as a treatment for rheumatoid arthritis (RA).
The FDA approved upadacitinib (Rinvoq) for adults with RA whose disease... Read more »
We learned last week that the FDA was investigating Novartis for manipulating animal data related to its $2 million-a-dose gene therapy Zolgensma. The activity took place at AveXis, the firm Novartis bought for $8.7 billion in 2018, and Novartis reportedly... Read more »
Imagine the transportation future 20 years from now. Here’s one way things could roll on a weekday: Many of us get picked up at home by a sturdy, standardized, driverless car that will also scoop up a few of our neighbors... Read more »
This week, we’re tracking venture capital deals in digital health, augmented reality for the enterprise, wellness, and food tech. Read on for details.
—Buoy Health said it snagged $15 million in a Series B funding round led by Hambrecht Ducera Growth... Read more »
TuSimple, an autonomous trucking company, has been conducting test drives for UPS between the Arizona cities of Phoenix and Tucson since May.
Now the corporate venture arm of the global package delivery giant says it has taken a minority stake in... Read more »
Plant-based meats and milks still use proteins, just not proteins that come from animals. Motif Ingredients has raised $27.5 million to build a pipeline of these animal-free protein ingredients.
In addition to the new cash, Motif on Thursday also unveiled a... Read more »
[Updated, 3:40 pm ET, see below] The Food and Drug Administration approved 59 new drugs last year, a record for the agency which over the years has swung back and forth between tight control and leniency. We are in... Read more »
Wireless giant Qualcomm has appointed Mark McLaughlin, the former CEO of network security company Palo Alto Networks, as chairman of its board of directors.
McLaughlin joined Silicon Valley-based Palo Alto Networks (NYSE: PANW) as president and CEO in 2011,... Read more »
After a nearly three-year period in which not a single digital health company held an initial public stock offering, the dry spell has ended.
In recent weeks, four healthcare software and technology businesses—Change Healthcare, Health Catalyst, Livongo Health, and Phreesia—held IPOs.... Read more »
Study of the human genome has yielded new insights into the origins of diseases and the pathways to potentially cure them. Join Xconomy and Biocom the evening of Aug. 27 to hear from leaders in the field for “Turning Genomics... Read more »
Amazon Web Services and other businesses that charge customers to host their software applications have become a popular option for tech startups. Part of the reason for the popularity of using AWS and other cloud computing services is because it allows... Read more »
It’s time to catch up on some recent headlines from Wisconsin’s innovation clusters:
—Venture Investors and American Family Ventures are making progress on raising new venture funds. Madison-based Venture Investors has closed on $73.1 million for its latest fund, and... Read more »